Chunggei launches pioglitazone 15 mg

Chunggei Pharm has launched pioglitazone 15 mg in a bid to expand its presence in domestic type 2 diabetes market under joint marketing with Schnell Pharmaceuticals Inc.

Pioglitazone is used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes.

Pioglitazone is in a class of medications called thiazolidinediones. It works by increasing the body'...